Antiretroviral Therapy
21
0
1
19
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
0.0%
0 terminated out of 21 trials
100.0%
+13.5% vs benchmark
19%
4 trials in Phase 3/4
5%
1 of 19 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 19 completed trials
Clinical Trials (21)
Enhancing Communication on Relationship Preservation, Safer Conception and PrEP to Promote HIV Testing in Uganda
Long Term Outcomes of Therapy in Women Initiated on Lifelong ART Because of Pregnancy in DR Congo
HIV Transmission in the Era of Scaling up Antiretroviral Therapy in Ethiopia
Survey of Procedures and Resources for Initiating Treatment of HIV in Africa-Malawi
Survey of Procedures and Resources for Initiating Treatment of HIV in Africa-South Africa
Survey of Procedures and Resources for Initiating Treatment of HIV in Africa-Zambia
First in Human Study of TLC-ART 101 (ACTU 2001)
Next Generation Ingestible Sensors for Medication Adherence Measurement
Timely Initiation of HIV Antiretroviral Therapy Among Those Who Delay/Decline
Antiretroviral Treatment Outcomes in HIV-HBV Co-infected Patients in Southern Africa
Revised Simplified Algorithm for Treatment Eligibility for HIV (SLATEII)
Continuation of Protease-Inhibitor Based Second-Line Therapy vs. Switch to B/F/TAF in Virologically Suppressed Adults
Effectiveness of Raltegravir-Based Antiretroviral Therapy in HIV-HCV Coinfected Liver Transplant Recipients
Smart Linkage-to-HIV Care Via a Smartphone App
Evaluation of a Simplified Strategy for the Long-term Management of HIV Infection (Simpl'HIV)
Improving Clinic Attendance for Medication Collection Among HIV Positive Individuals in Nepal
Raltegravir Switch for Toxicity or Adverse Events
Mobile Phone Technology for Prevention of Mother-to-Child Transmission of HIV: Acceptability, Effectiveness, and Cost
Unboosted Atazanavir as Initial ART Therapy in China
Efavirenz to Nevirapine Switch and Low-Density Lipoprotein (LDL)-Dyslipidemia